Skip to main content
Aligned Genetics, Inc. logo

Aligned Genetics, Inc. — Investor Relations & Filings

Ticker · 238120 ISIN · KR7238120000 KO Manufacturing
Filings indexed 140 across all filing types
Latest filing 2020-02-07 Earnings Release
Country KR South Korea
Listing KO 238120

About Aligned Genetics, Inc.

https://en.alignedgenetics.com

Aligned Genetics, Inc. is a company that develops, manufactures, and sells advanced solutions for cellular imaging, biomolecular analysis, and molecular diagnostics. It provides cutting-edge equipment, automated systems, imaging instruments, and reagents for laboratories in the life science and medical fields. The company focuses on developing molecular diagnostic solutions that deliver rapid and accurate results to support faster clinical care. Aligned Genetics aims to improve human health by creating technologies that offer deeper insights into cellular and molecular processes.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from Logos Bio regarding a significant change (over 30%) in revenue or profit structure. It provides preliminary financial results (sales, operating profit, net income) and explains the reasons for the change. This is a standard earnings-related disclosure required by regulatory bodies (like the KRX in Korea) for listed companies, which falls under the 'Earnings Release' category as it provides key financial highlights before the final audit. FY 2019
2020-02-07 Korean
주주총회소집결의
AGM Information Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Logos Biosystems. It outlines the date, time, location, and agenda items (such as approval of financial statements and director remuneration). This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2020-02-07 Korean
기타경영사항(특허권취득)(자율공시)(라인 스캐닝 방식의 공초점 현미경에서의 자동초점조절 방법 및 장치)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by Logos Biosystems. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a regulatory disclosure of a corporate event, it falls under the general regulatory filing category.
2019-12-17 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the suspension of share registration (shareholder register closure) for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting. It does not contain the full report or proxy materials, but rather serves as a formal notice of a corporate action. Given the nature of the announcement regarding shareholder rights and meeting preparation, it falls under the general regulatory filing category.
2019-12-13 Korean
조회공시요구(현저한시황변동)에대한답변(중요정보없음)
Regulatory Filings Classification · 95% confidence The document is a formal response to a regulatory inquiry from the Korea Exchange regarding significant market fluctuations (unusual stock price/volume activity). It explicitly states that the company has no material information to disclose. As this is a standard regulatory disclosure regarding market activity and does not fit into specific categories like earnings, dividends, or management changes, it is classified as a general regulatory filing.
2019-11-27 Korean
조회공시요구(현저한시황변동)
Regulatory Filings Classification · 95% confidence The document is a formal request from a regulatory body (likely an exchange) to the company LogosBio regarding 'significant market fluctuations' (현저한 시황변동). It asks the company to disclose whether there are any undisclosed material events affecting the stock price. This is a standard regulatory inquiry/announcement and does not fit into specific categories like financial reports or dividend notices, making it a regulatory filing.
2019-11-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.